Kodiak Sciences, Inc. (KOD)
108.25
-1.09
(-1.00%)
USD |
NASDAQ |
Nov 12, 16:00
105.01
-3.24
(-2.99%)
After-Hours: 06:50
Kodiak Sciences Market Cap : 6.801B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 6.801B |
| November 11, 2026 | 6.870B |
| November 10, 2026 | 6.790B |
| November 09, 2026 | 6.729B |
| November 06, 2026 | 6.239B |
| November 05, 2026 | 5.719B |
| November 04, 2026 | 6.189B |
| November 03, 2026 | 6.213B |
| November 02, 2026 | 6.134B |
| October 30, 2026 | 6.232B |
| October 29, 2026 | 6.308B |
| October 28, 2026 | 6.097B |
| October 27, 2026 | 5.738B |
| October 26, 2026 | 5.630B |
| October 23, 2026 | 5.506B |
| October 22, 2026 | 5.390B |
| October 21, 2026 | 5.512B |
| October 20, 2026 | 5.841B |
| October 19, 2026 | 5.740B |
| October 16, 2026 | 5.388B |
| October 15, 2026 | 5.537B |
| October 14, 2026 | 5.095B |
| October 13, 2026 | 5.757B |
| October 12, 2026 | 6.237B |
| October 09, 2026 | 6.275B |
| Date | Value |
|---|---|
| October 08, 2026 | 5.922B |
| October 07, 2026 | 5.723B |
| October 06, 2026 | 5.802B |
| October 05, 2026 | 5.894B |
| October 02, 2026 | 5.934B |
| October 01, 2026 | 6.186B |
| September 30, 2026 | 5.956B |
| September 29, 2026 | 5.725B |
| September 28, 2026 | 5.650B |
| September 25, 2026 | 2.033B |
| September 24, 2026 | 2.087B |
| September 23, 2026 | 1.980B |
| September 22, 2026 | 2.124B |
| September 21, 2026 | 2.037B |
| September 18, 2026 | 2.055B |
| September 17, 2026 | 2.064B |
| September 16, 2026 | 2.059B |
| September 15, 2026 | 2.073B |
| September 14, 2026 | 2.082B |
| September 11, 2026 | 2.067B |
| September 10, 2026 | 2.065B |
| September 09, 2026 | 2.122B |
| September 08, 2026 | 2.203B |
| September 04, 2026 | 2.222B |
| September 03, 2026 | 2.285B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 98.35B |
| AbbVie, Inc. | 520.44B |
| Mirum Pharmaceuticals, Inc. | 6.086B |
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
Market Cap Related Metrics
| PEG Ratio | -2.436 |
| Price to Book Value | 111.32 |
| Price | 108.25 |
| Earnings Yield | -3.87% |
| PEGY Ratio | -2.436 |